Not all sufferers with CLL demand therapy. Even with all modern innovations, the iwCLL still suggests watchful observation for clients with asymptomatic disease.86 This advice relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclop